Deep learning framework DeepAIR could improve understanding of adaptive immunity

Researchers presented a deep learning framework, DeepAIR, to accurately predict adaptive immune receptor (AIR)-antigen binding.

Vaccine experts urge more inclusivity in clinical trials

The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the trials that

September 5, 2023

Formycon hosts conference call on the results of the first quarter 2024 – Biotech Investments

EQS-News: Formycon AG / Key word(s): Quarterly / Interim Statement/Conference Formycon hosts conference call on the results of the first quarter 2024 02.05.2024 / 07:30

May 3, 2024

Sanofi’s $1.7B rare disease gambit; CAR-T boxed warning saga; New biotechs on Nasdaq; A seller’s market for M&A?; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

January 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.